NIFTY
90.20  0.95%
 9580.30
S&P BSE SENSEX
223.51  0.69%
 32424.1
Lupin Ltd.
NSE : LUPIN BSE : 500257 ISIN code : INE326A01037
on 29-May-2020
NSE
-11.35    -1.29%
Rs. 869.80
 
Days Low
Rs. 840.4
Days High
Rs. 881.5

Open Rs. 870
 
52 week Low
Rs. 505
52 week High
Rs.919
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
BSE
Rs.869.80
-11.65    -1.32%
on 29-May-2020
BSE
-11.65    -1.32%
Rs. 869.80
 
Days Low
Rs. 840.5
Days High
Rs. 881.8

Open Rs. 870
 
52 week Low
Rs. 504.75
52 week High
Rs.919.2
 
 
Bid :                 0.00 (0)
Offer :        0.00 (0)
NSE
Rs.869.80
-11.35    -1.29%
 
 
Last Price (Rs.)  869.80 Value  251973614.00
Net Change (Rs.)  -11.65 Best Buy  0.00
Volume  292657 Best Sell  0.00
Prev.Close (Rs.)  881.45 Best Quantity  0
Open (Rs.)  870.00 Sell Quantity  0
High (Rs.)  881.50 52-Week High (Rs.)  919.00
Low (Rs.)  840.40 52-Week Low (Rs.)  505.00
Face Value (Rs.)  2 Market Cap.(Rs/ Mn)  394071.60
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital905.00 904.20 903.20 
Share Capital905.00 904.20 903.20 
Share Capital905.00 904.20 903.20 
Share Capital905.00 904.20 903.20 
Share Capital905.00 904.20 903.20 
Currents Investments21073.80 2325.90 21120.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 475.45 1140764 105.10 139.69 0.58
Dr. Reddys Lab 4073.80 676952 914.23 52.94 0.61
Divis Lab 2395.75 635996 280.36 47.72 0.67
Cipla 647.60 522121 215.85 27.63 0.46
Aurobindo Pharma 745.05 436554 213.23 28.54 0.34
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Dec 2019Sep 2019Jun 2019
Net Sales27159.0028853.6029408.00
Operating Profit4856.207033.707484.90
PBDT866.803123.507380.30
Net Profit-814.701378.004459.30
More> 
 
Company News
5/22/2020 12:00:00 AM
Lupin gets USFDA’s nod for Trientine Hydrochloride Capsules USP
5/22/2020 12:00:00 AM
Lupin gains on getting USFDA’s nod for Trientine Hydrochloride Capsule...
5/19/2020 12:00:00 AM
Lupin launches authorized generic version of Apriso
More>
 
Ratios
   Earnings Per Share (Rs)34.01 
   Book NAV/Share(Rs)373.46 
   PAT Margin (%)12.71 
   Asset Turnover(x)0.63 
   PER(x)21.73 
   Yield(%)0.68 
   EV/Core EBITDA(x)10.62 
   M Cap / Sales2.94 
   Net Sales Growth(%)12.57 
   PAT Growth(%)14.44 
   Total Debt/Equity(x)0.00 
   Current Ratio(x)4.75 
   Quick Ratio(x)3.59 
   Total Debt/Mcap(x)0.00 
More>